S
SAB Biotherapeutics (SABS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About SAB Biotherapeutics (SABS)
SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of immunotherapeutic polyclonal human antibodies to treat and prevent infectious diseases and immune and autoimmune disorders. Its DiversitAb pl... Read more
- USD3.70
- USD3.79
- USD3.51
- USD6.30
- -10.30%
- 2M
- 66.50k
- 74.09k
- 35M
- 2.16
- -38.80%
Stock News
yesterday
What’s the best way to convince 20-year-olds to save for retirement?
MarketWatch
yesterday
What's behind the move in AI infrastructure stocks — plus, Meta sticks with efficiency mantra
CNBC
yesterday
Eli Lilly shares tumble after cutting its sales outlook. What it means for investors
CNBC
yesterday
Healthcare slumps, tech rebounds — here are our stocks that are moving and why
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
